معرفی
Prof. Ulrich Jaehde is a Professor at the Pharmazeutisches Institut of the Rheinische Friedrich-Wilhelms-Universität Bonn. His research focuses on developing pharmacometric models for anticancer drugs to optimize therapy, integrating pharmacokinetics, pharmacodynamics, and clinical outcomes. He specializes in PBPK modeling for elderly populations and risk models to predict adverse drug reactions. His team contributes to the Medical Informatics Initiative Germany, advancing IT-based medication safety for polypharmacy patients. Recent work includes optimizing paclitaxel dosing in lung cancer, validating PRO-CTCAE tools for adverse event reporting, and integrating pharmacogenetic data into treatment strategies. Collaborations span academia and clinical settings, emphasizing translational research to improve patient outcomes.
